Belgium, Benin, Burundi, China, Ethiopia, Georgia, Ireland, Kyrgyzstan, Lesotho, Malawi, Mozambique
Peru, South Africa, Sweden, Tanzania, Uganda, Ukraine, United Kingdom, USA, Vietnam, Zambia
Researching National & Subnational Effects of Global HIV/AIDS Initiatives at the Country Level
Search the GHIN database for original
research on the impact of HIV/AIDS GHIs
GHIN database advanced search
Author(s) |
Lydon P. Levine R. Makinen M et al |
---|---|
Date |
December 2008 |
Reference |
Vaccine Volume 26, Issue 51, pp6706-6716 |
Web Link | |
Organisation |
Expanded Programme on Immunization (EPI) |
Keywords |
Funding; GAVI. |
Study Type |
Independent desk-based review. |
Aims |
To review the experience of GAVI introducing Hep B and Haemophilus influenzae type b vaccines in the poorest countries; explore how financing has changed since GAVI Fund resources were made available during its first wave of support 2000-20006; to test the original assumptions of GAVI financing approach against realities of wide set of countries. NB: This paper is the second in a series of three papers describing the work of the Financing Task Force in the first five years of the GAVI Alliance. The first document focuses on the Financing Task Force as a model for interagency coordination, and the third one looks at national strategies for achieving financial sustainability in the poorest countries funded by GAVI. |
Methods |
Quantitative and qualitative analysis of immunization expenditure and financing data from GAVIs Financing Taskforce database, using a subset of 50 of the 75 GAVI countries for which the information reported in countries Financial Sustainability Plan was deemed of sufficiently high quality and comparability.. Data presented compare baseline before GAVI, a year with GAVI support, and a future projected period between 2005-10 (to capture phase out and transition to national and partner financing). |
Findings |
Expenditures for routine immunization have increased from $6 before GAVI, to $9.2 one year in, to projected $17.5 per infant for 2005-10. Scale up of immunization during this latter period must therefore increase by a factor of three compared to baseline. In addition, the review found that...
|
Conclusions / Recommendations |
|